Tudor Investment Corp’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$623K	Buy	107,414 +85,228	+384%	+$565K	﹤0.01%	2676
2025 Q4	$174K	Sell	22,186 -15,808	-42%	-$124K	﹤0.01%	3327
2025 Q3	$309K	Sell	37,994 -187,192	-83%	-$1.24M	﹤0.01%	2957
2025 Q2	$1.05M	Hold	225,186	–	–	0.01%	2101
2025 Q1	$1.24M	Sell	225,186 -80,000	-26%	-$323K	0.01%	1676
2024 Q4	$1.03M	Sell	305,186 -202,171	-40%	-$650K	0.01%	1707
2024 Q3	$1.45M	Sell	507,357 -65,829	-11%	-$169K	0.02%	1405
2024 Q2	$1.29M	Hold	573,186	–	–	0.01%	1324
2024 Q1	$1.27M	Buy	573,186 +19,775	+4%	+$51.2K	0.02%	1224
2023 Q4	$1.3M	Sell	553,411 -88,087	-14%	-$163K	0.02%	1324
2023 Q3	$1.19M	Sell	641,498 -216,913	-25%	-$497K	0.02%	1211
2023 Q2	$2.25M	Sell	858,411 -101,700	-11%	-$259K	0.04%	835
2023 Q1	$1.56M	Hold	960,111	–	–	0.03%	920
2022 Q4	$1.28M	Hold	960,111	–	–	0.03%	934
2022 Q3	$1.5M	Hold	960,111	–	–	0.04%	663
2022 Q2	$1.48M	Sell	960,111 -1,081	-0.1%	-$2.28K	0.04%	661
2022 Q1	$2.46M	Buy	961,192 +1,081	+0.1%	+$2.64K	0.06%	452
2021 Q4	$2.81M	Buy	+960,111	New	+$2.07M	0.05%	482